Annual Reports

 
Quarterly Reports

 
8-K

 
Other

  • NT 10-Q (Nov 15, 2017)
  • NT 10-Q (Aug 15, 2017)
  • Form 3 (Aug 1, 2017)
  • Form 3 (Jul 21, 2017)
  • NT 10-Q (May 16, 2017)
  • NT 10-K (Mar 31, 2017)
ERBA Diagnostics, Inc. DEFA14A 2011

Documents found in this filing:

  1. Defa14A
  2. Graphic
  3. Graphic

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934

Filed by the Registrant [X]

Filed by a Party other than the Registrant [ ]

Check the appropriate box:

[    ]  
  Preliminary Proxy Statement

[    ]  
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

[    ]  
  Definitive Proxy Statement

[X]  
  Definitive Additional Materials

[    ]  
  Soliciting Material Pursuant to Section 240.14a-12

IVAX Diagnostics, Inc.
(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[X]  
  No fee required.

[    ]  
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)  
  Title of each class of securities to which transaction applies:

(2)  
  Aggregate number of securities to which transaction applies:

(3)  
  Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):

(4)  
  Proposed maximum aggregate value of transaction:

(5)  
  Total fee paid:

[    ]  
  Fee paid previously with preliminary materials.

[    ]  
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)  
  Amount Previously Paid:

(2)  
  Form, Schedule or Registration Statement No.:

(3)  
  Filing Party:

(4)  
  Date Filed:


IVAX Diagnostics, Inc.
2140 North Miami Avenue
Miami, Florida 33127

May 9, 2011

Dear Stockholder:

We are writing to again remind you of the importance of voting your shares of our Common Stock on the proposals to be considered at our upcoming 2011 Annual Meeting of Stockholders to be held on May 20, 2011. The Annual Meeting is now only days away and, according to our latest records, we have not yet received your vote.

We previously mailed to you proxy materials, including a Notice of Meeting, Proxy Statement and Proxy Card, for the Annual Meeting containing detailed descriptions of the proposals to be considered at the Annual Meeting. Please refer to the proxy materials for additional information.

We are asking that you vote “FOR” all of the proposals to be considered at the Annual Meeting, as recommended by our Board of Directors.

Your failure to vote will have the same effect as a vote cast “AGAINST” three of the proposals to be considered at the Annual Meeting.

We urge you to please complete, sign and return the enclosed Proxy Card (or follow the telephone and Internet voting instructions on your Proxy Card) today. If you hold your shares through a broker, bank or other nominee, then it is important that you promptly give voting instructions to your broker, bank or other nominee by following the voting instructions that you received from your broker, bank or other nominee. Your vote is important regardless of how many shares you own.

If you have recently mailed your Proxy Card (or voted by telephone or Internet) or provided voting instructions to your broker, bank or other nominee, then please accept our sincere appreciation and disregard this request.

If you have any questions or need assistance voting your shares, please call Georgeson Inc., our proxy solicitor for the Annual Meeting, toll-free at 1-866-297-1410.

We appreciate your time and consideration and your continued support of our Company.

Sincerely,

Kevin D. Clark,
President, Chief Executive Officer
and Chief Operating Officer


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki